VIDO research provides insight into the immune response and possible long-term health impacts associated with COVID-19

One of the newest scientists at the University of Saskatchewan’s (USask) Vaccine and Infectious Disease Organization (VIDO) has published new research on potential lasting effects of COVID-19.

Dr. Alyson Kelvin (PhD) came to VIDO in February 2020 as a visiting scientist to access the containment level 3 facilities and conduct research to help develop potential solutions to COVID-19. In July 2020, she was seconded from her position at Dalhousie University, and has since decided to stay at VIDO, officially joining the team this August.

https://www.vido.org/news/vido-research-provides-insight-into-the-immune-response-and-possible-long-term-health-impacts-associated-with-covid-19